Procter & Gamble Health Ltd Financials
Company Logo

Procter & Gamble Health Ltd Financial Statement

Procter & Gamble Health Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue314.10
Operating Expense230.07
Net Profit61.18
Net Profit Margin19.48
Earning Per Share36.86
EBIDTA87.39
Effective Tax Rate24.65

Procter & Gamble Health Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Jun 2024
Total Revenue Annual1,151.26
Operating Expenses Annual845.26
Operating Profit Annual301.44
Interest Annual0.72
Depreciation27.40
Net Profit Annual200.98
Tax Annual72.34

Procter & Gamble Health Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Jun 2024
Cash Flow at the Beginning435.42
Cash Flow from Operations228.28
Cash Flow from Investing-6.87
Cash Flow from Financing-418.10
Cash Flow at the End238.73

Procter & Gamble Health Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Jun 2024
PBDIT Margin (%)26.18
PBIT Margin (%)23.80
PBT Margin (%)-9.26
Net PROFIT Margin (%)17.46
Return On Networth / Equity (%)31.18
Return On Networth /Employed (%)39.76
Return On Assets (%)29.15
Total Debt / Equity (X)0.02
Asset Turnover Ratio (%)1.67

Procter & Gamble Health Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Jun 2024
Fixed Assets Annual126.60
Total Current Assets Annual524.22
Non Current Assets Annual270.14
Total Shareholders Funds Annual538.24
Total Assets Annual794.36

Procter & Gamble Health Ltd Earning Calls

No Data Availabe

FAQS on Procter & Gamble Health Ltd Financials

As of Jun 16, 2025, Procter & Gamble Health Ltd has a market capitalization of 8,382.44 Cr. Value Research classifies it as a Mid-Cap company.

Yes, Procter & Gamble Health Ltd is with a debt-to-equity ratio of 0.02.

In FY 2024 , Procter & Gamble Health Ltd recorded a total revenue of approximately 1,151.26 Cr marking a significant milestone in the company's financial performance.

Procter & Gamble Health Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and 0.0% annually, respectively..

Procter & Gamble Health Ltd's current PE ratio is 41.71.

Procter & Gamble Health Ltd's ROCE averaged 44.1% from the FY ending March 2022 to 2024, with a median of 41.3%. It peaked at 50.0% in March 2024, reflecting strong capital efficiency over the period..

Procter & Gamble Health Ltd's latest EBIT is Rs. 274.04 Cr, surpassing the average EBIT of Rs. 280.93 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions